Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Selling, General & Administrative
Dexcom Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Selling, General & Administrative
-$1.2B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-30%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Selling, General & Administrative
-$4.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Selling, General & Administrative
-$5.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
Stryker Corp
NYSE:SYK
|
Selling, General & Administrative
-$6.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
Abbott Laboratories
NYSE:ABT
|
Selling, General & Administrative
-$11.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Selling, General & Administrative
-$2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-12%
|
See Also
What is Dexcom Inc's Selling, General & Administrative?
Selling, General & Administrative
-1.2B
USD
Based on the financial report for Dec 31, 2023, Dexcom Inc's Selling, General & Administrative amounts to -1.2B USD.
What is Dexcom Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-30%
Over the last year, the Selling, General & Administrative growth was -18%. The average annual Selling, General & Administrative growth rates for Dexcom Inc have been -24% over the past three years , -22% over the past five years , and -30% over the past ten years .